Evident Vascular, a San Jose, CA-based medical technology company providing an intravascular ultrasound (IVUS) platform, raised an undisclosed amount in Series B funding.
Backers included Shangbay Capital and two undisclosed multinational strategics joining founding investor Vensana Capital.
The company intends to use the funds to accelerate the development of its advanced IVUS technology designed to enhance vascular imaging and patient outcomes and support 510(k) FDA clearance ahead of U.S. market launch.
Led by CEO Howard Rosen, Evident Vascular develops an advanced intravascular ultrasound (IVUS) platform designed to optimize vascular imaging for peripheral and coronary interventions. With the integration of artificial intelligence, it enhances image interpretation, streamlines workflows, and drives improved clinical outcomes.
FinSMEs
25/03/2025